Investigator's choice of Chemotherapy
ZN-c3-020
Phase 3 small_molecule active
Quick answer
Investigator's choice of Chemotherapy for Ovarian Cancer is a Phase 3 program (small_molecule) at Zentalis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zentalis Pharmaceuticals
- Indication
- Ovarian Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active